Role of Advocates in Research: The Research Advocate Network (RAN) as a Model for Advocate Participation
Judy Perotti, MS, is a co-founder of Research Advocacy Network (RAN) and was the former Director of Patient Services at Y-ME National Breast Cancer Organization. She authored Understanding Your Breast Cancer Pathology Report, a brochure for breast cancer patients, and is a member of the ASCO Aromatase Inhibitors Technology Assessment Panel, NCI Program for the Assessment of Clinical Cancer Tests Breast Cancer Working Group, and the NCCTG and NSABP Patient Advocacy Committees.
Elda Railey is a co-founder of RAN and formerly Director of Grants for the Susan G. Komen Breast Cancer Foundation. She has reviewed for Komen, Avon-NCI, and the CDC. She is a member of the Intercultural Cancer Council and serves on the UCSF Breast Cancer SPORE and Redes En Accion External Advisory Boards. She formerly served on the ACOSOG Patient Advocate Committee, and is currently the editor of Network News and director of the Advocate Institute.
Mary Lou Smith, JD, MBA, is a co-founder of RAN and co-chair of the ECOG Patient Representative Committee. She serves on the NCCN Breast Cancer Treatment and Screening Guidelines Committees and the North Central Cancer Treatment Group and Radiation Therapy Oncology Group Patient Advocate Committees. She is an advocate on caBIG and a community member of the IRB at Rush University Medical Center.
Cheya Pope is an Advocacy Relations Specialist, providing strategic counsel on patient advocacy issues and program planning for clients in the biotech and pharmaceutical industries. She has 10 years' experience in community relations and patient advocacy. She previously worked in Advocacy Relations for Genentech, Inc., where she was responsible for strategically developing and leveraging relationships with advocates from over 30 cancer advocacy organizatons.
© 2019-2023 National Comprehensive Cancer Network